AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 21 min read$VRSK

Shavel Lee sold $603K of VRSK

Shavel Lee (Chief Executive Officer) sold 3,535 shares of Verisk Analytics, Inc. (VRSK) at $170.70 ($0.60M total) on 2026-10-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Shavel Lee
Published Oct 2, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$VRSK
Bearish
medium confidence
Mentioned
$VRSK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKBearishLow
01

Why it matters

The disclosed sale may prompt short sellers and cause a slight dip in VRSK's price, though the pre‑arranged nature tempers the signal.

02

Market read

Insider sales by top executives are closely watched; this filing provides fresh data for short‑term positioning.

03

What to watch

The 10b5‑1 plan indicates the sale was pre‑scheduled, reducing the likelihood of new negative information.

Relevance 4/10Novelty 4/10Timing: after-hours filing today

Background

Form 4 filings disclose insider transactions; a CEO sale is noteworthy for traders monitoring ownership changes.

Company-level read

Ticker impact

$VRSKBearishMedium confidence
Context

CEO Shavel Lee sold 3,535 shares for $603,424, reducing his stake to 98,490 shares via a 10b5-1 plan.

Expected impact

likely modest downward pressure as the market prices in the insider sell

Evidence & confidence

A $603K sale by the chief executive is a material insider transaction that often leads to short-term selling pressure.

Market effects

Sector

Minimal impact on the data analytics sector; investors may watch for further insider activity.

Regional

U.S. market only; no broader regional effect.

Global

Limited to investors tracking Verisk Analytics.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event under a pre‑arranged plan, not a negative signal.

Key entities

  • Company
    Verisk Analytics, Inc.

    Provider of data analytics and risk assessment solutions.

  • Executive
    Shavel Lee

    Chief Executive Officer of Verisk Analytics.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

VRSK insider trading history →

Related articles

SEP 8
$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

gurufocus.com2 min
AUG 29
$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

simplywall.st2 min
AUG 28
$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).

finance.yahoo.com3 min
AUG 19
$VRSKMedAI 8/10

Verisk Analytics v. AccuLynx: Sorry, You Actually DO Have To Comply With That Second Request

The Delaware Court of Chancery ordered Verisk Analytics to continue pursuing FTC clearance for its $2.35 billion acquisition of AccuLynx, despite Verisk's attempt to terminate the deal. The court ruled that Verisk's termination was invalid due to its willful conduct in ending negotiations with a competitor, ServiceTitan. Verisk must now comply with a costly Second Request process, which typically takes many months to complete. The court's decision is notable as it is the first to compel a buyer

marketscreener.com2 min